期刊文献+

PF、TP同步放化疗在宫颈癌治疗中的疗效差异及对血清CA125、CA199水平的影响 被引量:4

The difference of curative effect of PF and TP concurrent radiotherapy and chemotherapy in the treatment of cervical cancer and its influence on serum CA125 and CA199 levels
下载PDF
导出
摘要 目的探讨在宫颈癌的治疗中采用氟尿嘧啶联合顺铂(PF)、紫杉醇联合顺铂(TP)进行同步放化疗的临床效果。方法选取2017年9月至2019年12月本院收治的宫颈癌患者96例展开研究,所有患者均接受同步放化疗。参照分层抽样分组的方式将患者分为A组和B组,每组各48例,其中A组接受PF化疗方案,B组接受TP化疗方案,对比两种化疗方案的临床效果。结果 B组总有效率为87.50%,明显高于A组的72.92%,差异有统计学意义(P<0.05)。治疗前A组和B组糖类抗原CA125和CA199水平比较,差异无统计学意义(P>0.05);治疗后,B组CA125、CA199水平低于A组,差异有统计学意义(P<0.05)。治疗前A组和B组阳性率比较,差异无统计学意义(P>0.05);治疗后,B组阳性率低于A组,差异有统计学意义(P<0.05)。A组与B组不良反应总发生率比较,差异无统计学意义(P>0.05)。结论无论是PF还是TP在宫颈癌同步放化疗中均可发挥显著的治疗效果,但相比之下,TP化疗方案可以在保障患者治疗安全性的同时,进一步调节机体CA125和CA199水平及阳性率,治疗优势更加显著。 Objective To investigate the clinical effect of concurrent radiotherapy and chemotherapy with fluorouracil combined with cisplatin(PF)and paclitaxel combined with cisplatin(TP)in the treatment of cervical cancer.Methods A total of 96 patients with cervical cancer admitted to our hospital were enrolled.All patients received concurrent radiotherapy and chemotherapy.The treatment period was from September 2017 to December 2019.According to the stratified sampling grouping method,the patients were divided into group A and group B,with 48 cases in each group.Group A received PF chemotherapy,and group B received TP chemotherapy.The clinical effects of the two chemotherapy programs were compared.Results The total effective rate in group B was 87.50%,which was higher than that of 72.92%in group A,and the difference was significant(P<0.05).There was no significant difference in the levels of carbohydrate antigen(CA)125 and CA199 between group A and group B before treatment(P>0.05).After treatment,the levels of CA125 and CA199 in group B were lower than those in the control group,and the difference was significant(P<0.05).There was no significant difference in the positive rate between group A and group B before treatment(P>0.05).After treatment,the positive rate in group B was lower than that in group A,and the difference was significant(P<0.05).There was no significant difference in the incidence of adverse reactions between group A and group B(P>0.05).Conclusion Both PF and TP can exert significant therapeutic effects in concurrent radiotherapy and chemotherapy for cervical cancer.However,TP chemotherapy can further regulate the body′s CA125 and CA199 levels and positive rate while ensuring patient safety,which has a more significant treatment advantage.
作者 高怡 高铭君 GAO Yi;GAO Mingjun(Ward 3,Department of Obstetrics,Dalian Maternal and Child Health Hospital,Dalian116000,China;Department of Clinical Medicine,Dalian Medical University,Dalian116044,China)
出处 《中国现代医生》 2021年第19期14-17,共4页 China Modern Doctor
关键词 宫颈癌 氟尿嘧啶 紫杉醇 顺铂 血清糖类抗原 不良反应 Cervical cancer Fluorouracil Paclitaxel Cisplatin Serum carbohydrate antigen Adverse reactions
  • 相关文献

参考文献20

二级参考文献178

  • 1王晓珊,陈琳,梁良.热疗联合同步放化疗治疗局部晚期宫颈癌的Meta分析[J].实用癌症杂志,2014,29(3):304-307. 被引量:7
  • 2杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1469
  • 3Duenas-Gonzalez A, Cetina-Perez L, Onate-Ocana LF, et al. Multimodal treatment of locally advanced cervical can- cer [J]. Arch Med Res,2005,36(11) : 129-135.
  • 4Chen JZ, Gu WY,Yang L. Nanotechnology in the manage- ment of cervical cancer [J]. Reviews in Medical Virology, 2015,25(1) : 72-83.
  • 5Peter WA, Liu PY, Barrett R J, et al. Concurrent chemother- apy and pelvic radiation therapy compared with pelvic ra- diation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix [J]. J Clin Oncol,2000,18(12) : 1606-1613.
  • 6Mainenti PP, Pizzuti LM, Segreto S, et al. Diffusion volume (DV) measurement in endometrial and cervical cancer:a new MRI parameter in the evaluation of the tumor grading and the risk classification [J]. European Journal of Radiol- ogy,2016,85 (1) : 113-124.
  • 7Keys HM, Bundy BN,Stehman FB,et al. Cisplatin,radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage I B cervical carci- noma [J]. N Eng J Med, 1999,340(15) :1154-1161.
  • 8Cho YG, Song JH, Kim CJ, et al. Genetic alterations of the ATBFlgene in gastric cancer[J]. Clin Cancer Res,2007,13 ( 15 ) : 4355 -4359.
  • 9Ozdemir NY,Abali H,Okslizoglu B,et al. The efficacy and safety of reduced--dose docetaxel,Cisplatin,and 5--fluorouracil in the first-line treatment of advanced stage gastric adeno- carcinoma [J]. Med Oncol,2010,27(3):680-684.
  • 10Bang Y,Kim YW,Yang H,et al. Adjuvant capecitabine and oxaliplatin for gastric cancer: Results of the phase Ⅲ CLASSIC trial [J]. J Olin Oncol, 2011,29(18) :LBA4002.

共引文献451

同被引文献78

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部